Status:
RECRUITING
Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
Lead Sponsor:
University of Milano Bicocca
Conditions:
Autoimmune Hepatitis
Liver Disorder
Eligibility:
All Genders
1+ years
Brief Summary
Autoimmune Hepatitis (AIH) is chronic fibroinflammatory disease of the liver characterized by chronic, relapsing liver inflammation, and a risk for progression to liver failure and need for liver tran...
Detailed Description
Autoimmune Hepatitis (AIH) is a chronic fibroinflammatory disease of the liver characterized by chronic, relapsing inflammation, and a risk for progression to liver failure and development of hepatoce...
Eligibility Criteria
Inclusion
- All AIH patients living in Italy and aged at least 1 year can be included in the database.
- Willing and able to give informed consent prior to any study specific procedure being
- Diagnosis of AIH according to the most recent published guidelines (EASL)
Exclusion
- Subject unwilling to participate at the study
Key Trial Info
Start Date :
March 29 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 29 2034
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06078098
Start Date
March 29 2023
End Date
March 29 2034
Last Update
October 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS San Gerardo dei Tintori
Monza, MB, Italy, 20900